These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34873830)

  • 1. Human placental mesenchymal stromal cell-derived exosome-enriched extracellular vesicles for chronic cutaneous graft-versus-host disease: A case report.
    Norooznezhad AH; Yarani R; Payandeh M; Hoseinkhani Z; Kiani S; Taghizadeh E; Thakor AS; Mansouri K
    J Cell Mol Med; 2022 Jan; 26(2):588-592. PubMed ID: 34873830
    [No Abstract]   [Full Text] [Related]  

  • 2. Mesenchymal stem cell-derived exosomes for managing graft-versus-host disease: An updated view.
    Shafeghat Z; Dorfaki M; Dehrouyeh S; Arab FL; Roozbehani M; Falak R; Faraji F; Jafari R
    Transpl Immunol; 2023 Dec; 81():101957. PubMed ID: 37935319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Graft-Versus-Host Disease Amelioration by Human Bone Marrow Mesenchymal Stromal/Stem Cell-Derived Extracellular Vesicles Is Associated with Peripheral Preservation of Naive T Cell Populations.
    Fujii S; Miura Y; Fujishiro A; Shindo T; Shimazu Y; Hirai H; Tahara H; Takaori-Kondo A; Ichinohe T; Maekawa T
    Stem Cells; 2018 Mar; 36(3):434-445. PubMed ID: 29239062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stromal cell exosome-enhanced regulatory T-cell production through an antigen-presenting cell-mediated pathway.
    Zhang B; Yeo RWY; Lai RC; Sim EWK; Chin KC; Lim SK
    Cytotherapy; 2018 May; 20(5):687-696. PubMed ID: 29622483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Placenta-Derived Decidua Stromal Cells for Treatment of Severe Acute Graft-Versus-Host Disease.
    Ringden O; Baygan A; Remberger M; Gustafsson B; Winiarski J; Khoein B; Moll G; Klingspor L; Westgren M; Sadeghi B
    Stem Cells Transl Med; 2018 Apr; 7(4):325-331. PubMed ID: 29533533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mesenchymal stromal/stem cell therapy for acute graft versus host disease: the next step].
    Miura Y; Fujii S
    Rinsho Ketsueki; 2020; 61(8):953-958. PubMed ID: 32908060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placenta-derived mesenchymal stromal cells and their exosomes exert therapeutic effects in Duchenne muscular dystrophy.
    Bier A; Berenstein P; Kronfeld N; Morgoulis D; Ziv-Av A; Goldstein H; Kazimirsky G; Cazacu S; Meir R; Popovtzer R; Dori A; Brodie C
    Biomaterials; 2018 Aug; 174():67-78. PubMed ID: 29783118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular Vesicles Released from Human Umbilical Cord-Derived Mesenchymal Stromal Cells Prevent Life-Threatening Acute Graft-Versus-Host Disease in a Mouse Model of Allogeneic Hematopoietic Stem Cell Transplantation.
    Wang L; Gu Z; Zhao X; Yang N; Wang F; Deng A; Zhao S; Luo L; Wei H; Guan L; Gao Z; Li Y; Wang L; Liu D; Gao C
    Stem Cells Dev; 2016 Dec; 25(24):1874-1883. PubMed ID: 27649744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal Stem Cell Extracellular Vesicles as a New Treatment Paradigm in Solid Abdominal Organ Transplantation: A Case Series.
    Lightner AL; Fujiki M; Elshawy M; Dadgar N; Barnoski A; Osman M; Fulmer CG; Vaidya A
    Stem Cells Dev; 2024 Mar; 33(5-6):107-116. PubMed ID: 38299936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Follow-Up After the Application of Mesenchymal Stromal Cells in Children and Adolescents with Steroid-Refractory Graft-Versus-Host Disease.
    Döring M; Cabanillas Stanchi KM; Lenglinger K; Treuner C; Gieseke F; Erbacher A; Mezger M; Vaegler M; Schlegel PG; Greil J; Bettoni da Cunha Riehm C; Faul C; Schumm M; Lang P; Handgretinger R; Müller I
    Stem Cells Dev; 2021 Mar; 30(5):234-246. PubMed ID: 33446053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal Stem Cell Derived Extracellular Vesicles: A Role in Hematopoietic Transplantation?
    De Luca L; Trino S; Laurenzana I; Lamorte D; Caivano A; Del Vecchio L; Musto P
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28486431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human placenta-derived mesenchymal stem cells ameliorate GVHD by modulating Th17/Tr1 balance via expression of PD-L2.
    Ma Y; Wang Z; Zhang A; Xu F; Zhao N; Xue J; Zhang H; Luan X
    Life Sci; 2018 Dec; 214():98-105. PubMed ID: 30393022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ressarch Advances of Prevantive and Therapeatic Effect of Mesenchymal Stromal Cells on Graft-Versus-Host Disease--Review].
    Wang L; Ma DX; Liu SF; Gao CJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Feb; 27(1):283-287. PubMed ID: 30738484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic prospects of MicroRNAs carried by mesenchymal stem cells-derived extracellular vesicles in autoimmune diseases.
    Liu H; Chen Y; Yin G; Xie Q
    Life Sci; 2021 Jul; 277():119458. PubMed ID: 33831424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular Vesicles After Allogeneic Hematopoietic Cell Transplantation: Emerging Role in Post-Transplant Complications.
    Lia G; Di Vito C; Cerrano M; Brunello L; Calcaterra F; Tapparo M; Giaccone L; Mavilio D; Bruno B
    Front Immunol; 2020; 11():422. PubMed ID: 32265915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal stromal cells for the prophylaxis and treatment of graft-versus-host disease-a meta-analysis.
    Morata-Tarifa C; Macías-Sánchez MDM; Gutiérrez-Pizarraya A; Sanchez-Pernaute R
    Stem Cell Res Ther; 2020 Feb; 11(1):64. PubMed ID: 32070420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical Studies of MSC-Derived Extracellular Vesicles to Treat or Prevent Graft Versus Host Disease: a Systematic Review of the Literature.
    Gupta M; Tieu A; Slobodian M; Shorr R; Burger D; Lalu MM; Allan DS
    Stem Cell Rev Rep; 2021 Apr; 17(2):332-340. PubMed ID: 33159616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical application of mesenchymal stem cells for hematological diseases].
    Taketani T
    Rinsho Ketsueki; 2018; 59(10):2362-2372. PubMed ID: 30305547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-1 Antitrypsin-Expressing Mesenchymal Stromal Cells Confer a Long-Term Survival Benefit in a Mouse Model of Lethal GvHD.
    Geiger S; Ozay EI; Geumann U; Hereth MK; Magnusson T; Shanthalingam S; Hirsch D; Kälin S; Günther C; Osborne BA; Tew GN; Hermann FG; Minter LM
    Mol Ther; 2019 Aug; 27(8):1436-1451. PubMed ID: 31138510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional dosing of mesenchymal stromal cell-derived extracellular vesicles for the prevention of acute graft-versus-host-disease.
    Dal Collo G; Adamo A; Gatti A; Tamellini E; Bazzoni R; Takam Kamga P; Tecchio C; Quaglia FM; Krampera M
    Stem Cells; 2020 May; 38(5):698-711. PubMed ID: 32064745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.